Invasive AspergillosisGAMSON, Katelyn; YILE DING; ARONOWITZ, Paul et al.Journal of general internal medicine. 2014, Vol 29, Num 4, pp 686-687, issn 0884-8734, 2 p.Article

Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysisYAO, Z.-W; LU, X; SHEN, C et al.European journal of clinical microbiology & infectious diseases (Print). 2014, Vol 33, Num 8, pp 1339-1344, issn 0934-9723, 6 p.Article

Enfumafungin Derivative MK-3118 Shows Increased In Vitro Potency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species IsolatesJIMENEZ-ORTIGOSA, Cristina; PADERU, Padmaja; MOTYL, Mary R et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 2, pp 1248-1251, issn 0066-4804, 4 p.Article

Immune Correlates of Protection in Human Invasive AspergillosisCAMARGO, Jose F; HUSAIN, Shahid.Clinical infectious diseases. 2014, Vol 59, Num 4, pp 569-577, issn 1058-4838, 9 p.Article

Micafungin for the treatment of invasive aspergillosisENOCH, D. A; IDRIS, S. F; ALIYU, S. H et al.The Journal of infection. 2014, Vol 68, Num 6, pp 507-526, issn 0163-4453, 20 p.Article

Population Pharmacokinetic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive AspergillosisPING LIU; MOULD, Diane R.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4718-4726, issn 0066-4804, 9 p.Article

Reversible Blindness in Cryptococcal Meningitis With Normal Intracranial Pressure: Case Report and Review of the LiteratureGHATALIA, Pooja A; VICK, Amanda; VATTOTH, Surjith et al.Clinical infectious diseases. 2014, Vol 59, Num 2, pp 310-313, issn 1058-4838, 4 p.Article

A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive AspergillosisKOO, Sophia; THOMAS, Horatio R; DANIELS, S. David et al.Clinical infectious diseases. 2014, Vol 59, Num 12, pp 1733-1740, issn 1058-4838, 8 p.Article

Cryptococcal IRIS in the anterior segment of the eyeLAAKS, Debbie; SMIT, Derrick P; MEYER, David et al.AIDS (London). 2013, Vol 27, Num 3, pp 489-490, issn 0269-9370, 2 p.Article

Evaluation of the In Vitro Activity of Voriconazole As Predictive of In Vivo Outcome in a Murine Aspergillus fumigatus Infection ModelSALAS, Valentina; PASTOR, F. Javier; CALVO, Enrique et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 3, pp 1404-1408, issn 0066-4804, 5 p.Article

In Vitro Antifungal Susceptibility of Clinically Relevant Species Belonging to Aspergillus Section FlaviGONCALVES, Sarah S; STCHIGEL, Alberto M; CANO, Josep et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 4, pp 1944-1947, issn 0066-4804, 4 p.Article

L'aspergillose invasive chez le patient atteint de leucémie = Invasive aspergillosis in patients with leukemiaLAFRAM, I; BENMILOUD, S; CHAOUKI, S et al.Journal de pédiatrie et de puériculture. 2013, Vol 26, Num 4, pp 228-231, issn 0987-7983, 4 p.Article

Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive AspergillosisWÜRTHWEIN, Gudrun; CORNELY, Oliver A; GROLL, Andreas H et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 4, pp 1664-1671, issn 0066-4804, 8 p.Article

Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settingsKENDI, Caroline; PENNER, Jeremy; KOECH, Julius et al.Postgraduate medical journal. 2013, Vol 89, Num 1048, pp 73-77, issn 0032-5473, 5 p.Article

The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in KenyaMEYER, A.-C. L; KENDI, C. K; PENNER, J. A et al.TM & IH. Tropical medicine & international health. 2013, Vol 18, Num 4, pp 495-503, issn 1360-2276, 9 p.Article

Immune Response, Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Lung DiseaseEICKMEIER, Olaf; RIEBER, Nikolaus; ECKRICH, Jonas et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 20, pp 3669-3678, issn 1381-6128, 10 p.Article

Immunotherapy in Invasive Fungal Infection - Focus on Invasive AspergillosisLEHRNBECHER, Thomas; KALKUM, Markus; CHAMPER, Jackson et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 20, pp 3689-3712, issn 1381-6128, 24 p.Article

Primary cutaneous cryptococcosis in a patient with CREST syndromeISHIKAWA, Emiko; YONEDA, Kozo; NAKAI, Kozo et al.EJD. European journal of dermatology. 2012, Vol 22, Num 3, pp 421-422, issn 1167-1122, 2 p.Article

Sinusite fongique allergique. Réponse du e-quid de marsDESMOTS, F; GABAUDAN, C; GEFFROY, Y et al.Journal de radiologie (Paris). 2012, Vol 93, Num 5, pp 442-448, issn 0221-0363, 7 p.Article

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trialJARVIS, Joseph N; MEINTJES, Graeme; REBE, Kevin et al.AIDS (London). 2012, Vol 26, Num 9, pp 1105-1113, issn 0269-9370, 9 p.Article

Donor-Derived Fungal Infections in Organ Transplant Recipients: Guidelines of the American Society of Transplantation, Infectious Diseases Community of PracticeSINGH, N; HUPRIKAR, S; BURDETTE, S. D et al.American journal of transplantation (Print). 2012, Vol 12, Num 9, pp 2414-2428, issn 1600-6135, 15 p.Article

Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndromeVEHRESCHILD, J. J; MÜLLER, C; FAROWSKI, F et al.European journal of clinical pharmacology. 2012, Vol 68, Num 6, pp 987-995, issn 0031-6970, 9 p.Article

In Vitro Pharmacokinetic/Pharmacodynamic Modeling of Voriconazole Activity against Aspergillus Species in a New In Vitro Dynamic ModelAL-SAIGH, R; ELEFANTI, A; VELEGRAKI, A et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 10, pp 5321-5327, issn 0066-4804, 7 p.Article

Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignanciesKUROSAWA, Mitsutoshi; YONEZUMI, Masakatsu; HIRAYAMA, Yasuo et al.International journal of hematology. 2012, Vol 96, Num 6, pp 748-757, issn 0925-5710, 10 p.Article

Invasive aspergillosis: drug-dispensing systems as a source of filamentous fungal contamination in high-risk units?GIBERT, P; BRUDIEU, E; TIMSIT, J. F et al.The Journal of hospital infection. 2012, Vol 82, Num 4, pp 293-296, issn 0195-6701, 4 p.Article